Written by While the market for Single Photon Emission Computed Tomography (SPECT) in India demonstrates strong growth potential, industry stakeholders face distinct regulatory, economic, and operational challenges. According to the India Single Photon Emission Computed Tomography Market Outlook, overcoming infrastructure bottlenecks and integrating next-generation detector technology will be critical to sustaining the modality’s growth trajectory alongside competing imaging techniques like PET/CT.
Regulatory Compliance and Infrastructure Hurdles
Operating a nuclear medicine facility in India involves strict regulatory oversight. Key operational challenges include:
AERB Licensing: Diagnostic centers must adhere to stringent guidelines enforced by the Atomic Energy Regulatory Board (AERB) regarding room layout, radiation safety, radiation safety officer (RSO) deployment, and waste disposal.
Specialized Human Resources: India faces a relative shortage of certified nuclear medicine physicians and qualified medical physicists, creating operational constraints for facility expansion in smaller cities.
Isotope Logistics: Radiopharmaceuticals like $^{99text{m}}text{Tc}$ have short half-lives, requiring robust, time-sensitive cold chain supply networks from reactor sites to clinical departments.
Technological Transformation: Solid-State CZT Detectors
The future of SPECT imaging in India lies in the adoption of Cadmium Zinc Telluride (CZT) digital detectors. Traditional SPECT systems rely on photomultiplier tubes and sodium iodide crystals, which limit spatial resolution and require higher radiopharmaceutical doses. CZT-based cameras offer:
Higher Resolution: Superior energy resolution and spatial clarity for earlier disease detection.
Dose Reduction: Significantly lower radiation doses for patients while maintaining image quality.
Faster Scan Times: Reduced acquisition times, enabling higher patient throughput in busy clinics.
Integration with AI and Theranostics
Artificial Intelligence (AI) algorithms are increasingly being integrated into SPECT image reconstruction, automated attenuation correction, and lesion quantification. Furthermore, the rise of nuclear theranostics—pairing diagnostic SPECT imaging with targeted radionuclide therapy—is cementing SPECT/CT’s position as a vital tool in personalized medicine across India’s evolving healthcare landscape.